Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_387563
Proper Citation: Aviva Systems Biology Cat# ARP32705_P050, RRID:AB_387563
Target Antigen: CITED1 (Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1) (against the middle region of CITED1) (50ug)
Host Organism: rabbit
Clonality: polyclonal
Comments: manufacturer recommendations: IgG ELISA; Western Blot; WB, IHC
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for CITED1 (Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1) Antibody (against the middle region of CITED1) (50ug).
No alerts have been found for CITED1 (Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1) Antibody (against the middle region of CITED1) (50ug).
Source: Antibody Registry